Insiders / Dandekar Atul

Dandekar Atul

CIK 2050167personinsider
Companies
1
First seen
Feb 2, 2026
Last activity
Mar 3, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Maze Therapeutics, Inc. · MAZEExecutive10,50366,64311

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Maze Therapeutics, Inc.Common Stock10,503Feb 27, 2026
Maze Therapeutics, Inc.Stock Option (Right to Buy)Derivative38,000Mar 2, 2026
Maze Therapeutics, Inc.Restricted Stock UnitsDerivative19,000Mar 2, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 27, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$172.0K-4K
-26.37%
10,503
0.02% of shares
medium
Feb 27, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$168.8K-4K
-20.77%
14,264
0.03% of shares
medium
Jan 29, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$154.1K-4K
-20.83%
13,303
0.02% of shares
medium
Jan 29, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$126.0K-3K
-21.05%
10,503
0.02% of shares
medium
Feb 27, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Common Stock
$78.2K+8K
+71.41%
18,003
0.03% of shares
low
Jan 29, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Common Stock
$78.2K+8K
+71.41%
18,003
0.03% of shares
low
Jan 29, 2026SellMAZE
Maze Therapeutics, Inc.
Common Stock
$51.8K-1K
-6.67%
16,803
0.03% of shares
low
Mar 2, 2026GrantMAZE
Maze Therapeutics, Inc.
Restricted Stock Units
+19K
19,000
0.03% of shares
low
Mar 2, 2026GrantMAZE
Maze Therapeutics, Inc.
Stock Option (Right to Buy)
+38K
38,000
0.07% of shares
low
Feb 27, 2026ExerciseMAZE
Maze Therapeutics, Inc.
Stock Option (Right to Buy)
-8K
-11.25%
59,143
0.11% of shares
low